Day: 22 March 2022

Kunal Shah Backed Fintech Startup ‘BankSathi’ gets IRDAI Insurance Licence

Vijay Raman

The New Licence allows BankSathi to start offering a more diverse portfolio of Insurance products to consumers through more than 5 lakh financial advisors Bangalore, Karnataka, India “This licence is a big milestone in our journey. BankSathi is growing in fintech and this move to insurance products will give us further momentum and accelerate our growth in this space. We are building a robust, full-service platform for our advisors and consumers base through innovative products in partnership with high quality financial Institutes and Insurers. This move will lead us closer…

Read More

‘Meet-Use-Experience’ initiative to reach 15,000 chefs launched to accelerate the distribution of Kikkoman Soy Sauce across the largest cities in India

Newsdeck

MUMBAI, India, March 21, 2022 /PRNewswire/ — The world’s leading producer of naturally brewed soy sauce, Kikkoman Corporation, today announces the launch of the ‘Meet-Use-Experience’ initiative as part of its ‘Kikkoman Honjozo Authentic Soy Sauce Experience’ that started in October 2021. A first of its kind, it is the largest sampling of Kikkoman Soy Sauce – Honjozo Authentic All-Purpose Soy Sauce – in India. 15,000 bottles of Kikkoman Soy Sauce will be distributed to the largest Indian cities – namely, the following seven Tier I cities – Mumbai, Delhi NCR,…

Read More

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg

Vijay Raman

MUMBAI, India, March 21, 2022 /PRNewswire/ — Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for its Lacosamide Tablets1 USP, 50 mg, 100 mg, 150 mg and 200 mg, the generic version of Vimpat®2 Tablets, 50 mg, 100 mg, 150 mg and 200 mg of UCB, Inc. The company plans to launch the product immediately. Commenting on the development, Robert Crockart, Chief Commercial Officer, Glenmark Pharmaceuticals Ltd, said, “The FDA approval for generic Lacosamide Tablets USP reiterates our ongoing…

Read More